These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients. Costanzo MR, Koch DM, Fisher SG, Heroux AL, Kao WG, Johnson MR. J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928 [Abstract] [Full Text] [Related]
3. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ, Gullestad L, Pak J, Slauson S, Valantine HA, Hunt SA. J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [Abstract] [Full Text] [Related]
4. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda. Chinnock R, Emery J, Larsen R, Baum M, Janner D, Razzouk A, Gundry S, Nehlsen-Cannarella S, Bailey L. J Heart Lung Transplant; 1995 Feb; 14(4):726-33. PubMed ID: 7578182 [Abstract] [Full Text] [Related]
5. Methotrexate pulse therapy in the treatment of recurrent acute heart rejection. Bourge RC, Kirklin JK, White-Williams C, Naftel DC, George JF, Morrow R, Tarkka M, Welborn JM. J Heart Lung Transplant; 1992 Feb; 11(6):1116-24. PubMed ID: 1457434 [Abstract] [Full Text] [Related]
6. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation? Wagner FM, Reichenspurner H, Uberfuhr P, Kur F, Kaulbach HG, Meiser BM, Ziegler U, Reichart B. J Heart Lung Transplant; 1994 Feb; 13(3):438-42; discussion 442-3. PubMed ID: 8061020 [Abstract] [Full Text] [Related]